Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 159403CONT18

Opportunity Information: Apply for CDC RFA GH15 159403CONT18

The grant opportunity titled "Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a continuation cooperative agreement offered by the Centers for Disease Control and Prevention (CDC), specifically through its Center for Global Health (CGH). It sits within the health activity category and is linked to CFDA number 93.067, which corresponds to CDC global HIV/AIDS-related programming. The overall purpose of the opportunity, based on the title and program framing, is to support efforts in Ukraine that strengthen the quality, consistency, and long-term durability of medication assisted treatment (MAT), a core intervention used to treat opioid use disorder and reduce related harms, including HIV transmission among people who inject drugs. The fact that it is funded under PEPFAR indicates that the work is aligned with HIV prevention and treatment goals, especially in key populations where substance use and HIV risk overlap.

This announcement is not an open competition. It is explicitly labeled as "Continuation" funding and is intended only for organizations that previously received awards under the earlier funding opportunity CDC-RFA-GH15-1594 with the same program title. In practical terms, that means new applicants would not be eligible to apply through this notice; instead, it functions as a mechanism for CDC to extend or continue financial support to an existing project or set of projects already underway. The "Eligible Applicants" field is listed as "Others," but the description clarifies that eligibility is restricted to prior awardees under the referenced earlier announcement. This structure is common for multi-year cooperative agreements where ongoing work depends on continued funding increments, performance, and program needs.

The funding instrument type is a cooperative agreement, which typically implies substantial federal involvement beyond what is seen in a standard grant. In cooperative agreements, CDC often provides technical direction, collaboration on monitoring and evaluation, and alignment with broader country and PEPFAR strategies. While the notice does not spell out specific activities, a program framed around improving MAT quality and sustainability in Ukraine would generally involve strengthening clinical and service delivery standards, expanding provider capacity through training and mentorship, improving patient retention and continuity of care, enhancing monitoring systems and data quality, and supporting policy or health system changes that help MAT services remain stable over time. Sustainability in this context usually includes planning for longer-term domestic financing, integrating services into routine health systems, and ensuring consistent supply chains and regulatory frameworks for MAT medications.

Key administrative details in the source data show that the opportunity number is CDC RFA GH15 159403CONT18, indicating it is a continuation action tied to the earlier GH15-1594 program. The original closing date was 2017-11-14, and the record creation date was 2017-09-13, placing this announcement in the 2017 funding cycle. The award ceiling is listed as 0 and the expected number of awards is blank, which often happens in continuation notices because the amounts and number of funded entities may already be determined by prior awards, annual appropriations, and internal budget allocations rather than by a competitive selection process. In other words, the announcement is primarily a formal continuation vehicle rather than a call for new proposals.

In summary, this opportunity represents CDC's continuation funding under PEPFAR to maintain and advance ongoing work in Ukraine aimed at improving and sustaining medication assisted treatment services, with the intent of supporting public health outcomes that intersect opioid use disorder treatment and HIV prevention. It is restricted to current grantees from the earlier CDC-RFA-GH15-1594 award and is administered as a cooperative agreement, reflecting an ongoing partnership model between CDC and the funded implementers.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-09-13.
• Applicants must submit their applications by 2017-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 159403CONT18

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: